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Eliciting maximal immune responses to highly divergent viruses is a challenge and a focus in AIDS vaccine development. Another challenge is
to identify the immune correlates of protective immunity. Recent AIDS vaccine design approaches attempt to use reconstructed centralized viral
sequences that minimize genetic differences to circulating viruses. Using these approaches, we derive and analyze consensus (CON), ancestral
(ANC), and center-of-tree (COT) sequences to represent intra-individual HIV-1 env variants encoding a range of diversities and phylogenetic
structures. Each reconstructed sequence significantly minimized genetic distances to extant sequences throughout the first 5 years of infection of
an individual. Interestingly, ANC sequences diverged and were not significantly better than extant sequences in minimizing genetic distances at
later stages of infection and disease, likely due to the development of a substantially asymmetric phylogeny. COT or CON sequences derived from
autologous virus samplings may be useful for increasing the sensitivity of assessments of immune reactivity against HIV.
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Viruses such as HIV-1, HCV, and others exist within an
infected individual as a complex mixture of closely related but
genetically distinct variants or the quasispecies (Eigen, 1993).
Highly error-prone replication, unique to each of these viruses,
leads to the generation and accumulation of such genetic
variants. In HIV-1, the error rate of reverse transcriptase has been
well characterized using various experimental systems (Mansky
and Temin, 1995; Pathak and Temin, 1990a, 1990b; Roberts et⁎ Corresponding author. Thomas E. Starzl Transplantation Institute, Depart-
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doi:10.1016/j.virol.2005.11.055al., 1988). In vivo, we have shown that HIV-1 consistently
accumulates mutations at a rate of about 1% per year in its env
(Shankarappa et al., 1999). A combination of such high rates of
mutation and the turnover of billions of virus particles in a day
(Ho et al., 1995; Wei et al., 1995) illustrates the enormity of the
onslaught of virus mutations within each individual.
Assessing the impact of these mutations on viral biology and
on viral interactions with the host helps to understand
pathogenesis and to develop interventions. However, because
of the huge number of mutations, studying the impact of
variation requires new and practical approaches to reduce
genetic complexity by deriving sequences that best represent the
pool of variants. Since a large number of mutations encoded by
these viruses are unique to each infected individual (Learn and
Mullins, 2003), distinguishing the background mutations from
438 G.S. Kesturu et al. / Virology 348 (2006) 437–448the biologically relevant changes also helps in the design of an
optimal sequence that can be used for immune reactivity and
therapeutic studies. Here, we propose the design of these
sequences using approaches currently being explored in the
development of AIDS vaccine and evaluate their relationship to
individual variants.
Evolution of HIV-1 at the inter- and intra-individual levels
share a number of similarities. At the inter-individual level, a
star-shaped phylogeny documented for HIV-1 represents the
accumulation of mutations along multiple lineages on an
ancestral backbone (Anderson et al., 2001; Myers et al., 1993).
At the intra-individual level, clonal R5 HIV-1 establishes the
infection (van 't Wout et al., 1994; Wolfs et al., 1992; Wolinsky
et al., 1992; Zhang et al., 1993; Zhu et al., 1993, 1996) and
accumulates mutations over time (Shankarappa et al., 1999;
Wolinsky et al., 1996). Even when multiple variants initiate
infection (Cornelissen et al., 1995; Learn et al., 2002; Poss et al.,
1998), selective pressures appear to lead to a homogenization
following the acute infection (Learn et al., 2002; Zhang et al.,
1993). Therefore, accumulation of mutations within an
individual immediately following the acute infection is
qualitatively similar to an inter-individual star topology.
However, over the long-term infection, mutations accumulate
over successive generations of continually evolving populations
and leads to a “ladder” shaped phylogenetic tree with
temporally spaced variants (Mullins et al., 2004; Shankarappa
et al., 1999; Wolinsky et al., 1996). Regardless, from the
perspective of a single time point, star-phylogeny continues to
best explain the phylogenetic relationship of variants at that
time point because each variant generally represents a different
set of mutations over an ancestral backbone sequence present at
the earlier time point. In spite of these similarities, inter- and
intra-individual viral evolution differs in a number of other
important and potentially confounding ways. For example, the
viral latency and compartmentalization are intra-individual
phenomena that have not been defined at the inter-individual
population level, but their equivalents are expected to exist. The
level of inter-individual viral diversity is often much higher than
intra-individual diversity.
The central role for immune system in the control of HIV-1
replication is incontrovertible. The hypothesis that genetic
heterogeneity in HIV-1 is driven by a dynamic and ongoing
recognition and escape of virus variants by the host immune
system is consistent with the documented differences in the
specificity of immune responses during acute and chronic stages
of the disease (Goulder et al., 2001) and the appearance of
differing escape mutations during early (Allen et al., 2000;
O'Connor et al., 2002) and later (Kelleher et al., 2001) stages of
infection. However, a number of other observations raise the
possibility that currently used methods fail to provide a full and
accurate description of anti-HIV-1 CD8+ T cell responses. First,
the breadth of viral mutations within an individual (Shankar-
appa et al., 1999; Wolinsky et al., 1996) cannot be explained by
the escape at one or a few immunodominant epitopes. Second,
mechanisms that lead to a large number of positively selected
amino acid sites (Ross and Rodrigo, 2002; Yamaguchi-Kabata
and Gojobori, 2000; Zanotto et al., 1999) are not understood.Finally, the use of autologous viral sequences (Altfeld et al.,
2003), toggled peptides encoding variants (Korber et al., 2005),
and the enhanced antigen presentation using dendritic cells
(Huang et al., 2003; Zhao et al., 2002) appears to identify
stronger and new CD8+ T cell responses that would otherwise
be missed. These arguments are also strengthened by a recent
report that links immune recognition with nearly two-thirds of
all persisting mutations observed in individuals (Allen et al.,
2005).
In the development of AIDS vaccine immunogens, issues
concerning viral diversity are being tackled by reconstructing
centralized immunogen sequences that minimize the genetic
distance to circulating viruses (Gao et al., 2004; Gaschen et al.,
2002; Learn and Mullins, 2000; Mullins et al., 2004; Nickle et
al., 2003a; Novitsky et al., 2002). By being genetically closer to
each of the circulating variants, such an immunogen is expected
to elicit the maximum immune response and thus hoped to be
protective. Two such computer generated env sequences have
been recently shown to confer functional biologic properties to
the virus and elicit immune responses that can recognize and
neutralize some strains of HIV-1 (Doria-Rose et al., 2005; Gao et
al., 2005). We propose that both the eliciting and testing of anti-
HIV-1 immune responses are two sides of the same issue and
requires the use of similar approaches. Unlike the vaccine
context, each infected individual harbors genetically distinct
virus and a population of variants whose composition changes
over time. Therefore, it is necessary to test the extent to which the
methods aimed at minimizing the genetic distances apply to
intra-individual variants exhibiting differing levels of diversity
and phylogenetic relationships observed over the course of
infection. Here, we derive and characterize the ability of three
centralized representative sequences, consensus, ancestral, and
COTsequences, to minimize the genetic distances for HIV-1 env
sampled from 13 consecutive time points over an 8-year period
in an individual. These sequences represented a wide spectrum
of changes typically observed in an individual. We show
significant differences in the phylogenetic relationship among
variants present at different times in the infection and document
its effects on the minimization of genetic distance. We also
propose the use of phylogenetic properties to test hypotheses
related to immune escape and the use of genetic analyses for
natural selection in designing reagents to test immune reactivity.
Results
Impact of diversity on the minimization of genetic distances
The goal of sequence reconstruction methods is to design a
sequence that minimizes the genetic distance to a set of variant
sequences. Therefore, we first sought to test whether the extent
of this minimization in the genetic distance is impacted by
changes in levels of diversity. Sequences used in this study
represented a broad spectrum of intra-individual nucleic acid
diversity, ranging from 0.2% (0.4% for amino acid sequences)
in the first post-infection time point to 6.2% (11.4% for amino
acid sequences) at about 6 years following infection. Fig. 1
illustrates the average values for pairwise nucleic and amino
Fig. 1. Minimization of genetic distances by the consensus, ancestral, and COT sequences at different time points over the course of infection. Genetic distances for the
nucleic acid (panel A) and amino acid (panel B) sequences were derived using the Kimura 2-parameter model for evolution and as p-distances, respectively. Genetic
distances corresponding to the average for the pairwise comparisons between individual variants are depicted as thick black lines. The average genetic distances
between each representative sequence and the individual variants at the corresponding time points are plotted as lines with symbols as identified in the figure.
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the corresponding consensus, ancestral, and COT sequences.
All three sequences reduced the genetic distances over the range
of viral diversity observed for the first 5 years. Subsequently,
ancestral sequences failed to minimize distances and were
unlike that for COT and consensus sequences. At these visits,
COTand consensus sequences also showed a departure from the
close concordance seen at the earlier visits.
The minimization in genetic distances by each of the
representative sequences was quantified to allow a better
comparison across time points and is illustrated in Fig. 2.
Overall, the COT sequences led to an average minimization of
28 ± 8% (mean ± SD) for amino acid sequences and 33 ± 5% for
nucleotide sequences. Analogous values for the consensus
sequences were 31 ± 5% for amino acid and 37 ± 3% for the
nucleic acid sequences. In contrast, the extent of minimization
of genetic distances was much reduced for the ancestral
sequences (13 ± 16% for amino acid and 21 ± 13% for the
nucleic acid sequences). As evident in Fig. 1, the discrepancy in
the minimization of genetic distance between the ancestral and
other sequences was strongest for the last four visits. Consistent
with this discrepancy, the number of amino acid differences
between the COT and ancestral sequences also increased
significantly (five or less amino acid differences for V09–
V17 vs. 13–18 amino acid differences for V18–V24). These
findings allowed us to conclude that the consensus and COT
sequences minimize genetic distances to similar extents over a
range of levels of diversity observed during the course ofinfection. In contrast, the ability of ancestral sequences to
minimize genetic distances can be different for sequences
sampled from different time points in the same individual.
Phylogeny of representative sequences
We next sought to evaluate the phylogeny of variants
sampled within each time point along with their representative
sequences as well as to test for a phylogenetic explanation for
the inability of ancestral sequences to minimize genetic
distances in the subset of later time points. In addition, since
the consensus, ancestral, and COT sequences were derived
separately using the subsets of sequences, we needed to test
their phylogenetic behavior when all the sequences were
included in the analysis. Fig. 3 illustrates the phylogenetic
relationship among sequences sampled from each time point
along with the three centralized representative sequences for
each corresponding time point. To provide a uniform frame of
reference across different comparisons and since ancestral
sequence is the explicitly designed parental sequence for each
group, each phylogram was rooted to the ancestral sequence.
The phylogram format, as contrasted with the radial format, also
helped us to better separate and illustrate the lineages.
The phylograms in Fig. 3 provide an overall snapshot of the
changes in phylogenetic relationship among viruses sampled at
each visit. The tree topology was generally similar when
comparing adjoining time points, and the dissimilarity between
phylograms increased with an increase in the length of time
Fig. 2. Differences in the minimization of amino acid distances by the consensus, ancestral, and COT sequence. Data illustrated in panel B of Fig. 1 were converted to
percentage differences and plotted. COTand consensus sequences minimized genetic distances to similar extents, whereas ancestral sequences varied in their ability to
minimize the distances. This dichotomy was pronounced for sequences sampled from the last four visits.
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completely identical, the phylograms could be classified into
two broad groups. In the first group (V09–V18), multiple
branches of similar branch lengths separated individual taxa or
major clusters, each projecting from a vertical backbone and
leading to an overall balanced shape. In contrast, a wide range
of branch lengths separated taxa in the second group (V19–
V24). According to the terminology previously described
(Mullins et al., 2004), the first group is analogous to aFig. 3. Phylogenetic relationship among sequences sampled at each time point and
represent the sequences sampled at each time point. Neighbor-joining phylograms w
Each phylogram was rooted to the ancestral sequences to provide a uniform frame
sequences were drawn to a different scale. Numbers next to the symbol within each p
the last four visits appears to strongly influence the branch lengths that separate thecombination of balanced, star, and lopsided tree shapes,
whereas the second group represents the ladder shape.
Consistent with the proposed models for phylogenetic
clustering of each representative sequence (Mullins et al.,
2004; Nickle et al., 2003a), consensus and COT sequences
clustered towards the middle of the tree, whereas the ancestral
sequences were off-centered in unrooted trees (not shown; Fig.
3 shows trees rooted to the ancestral sequences). During the first
5 years of infection, small branch lengths separating the threethe corresponding consensus, ancestral, and COT sequences reconstructed to
ere generated using maximum likelihood distances estimated for each data set.
of reference across different phylogenies. Due to low genetic diversity, V09
anel represent the years following seroconverson. The asymmetric phylogeny in
ancestral from other representative sequences.
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between them (only horizontal lengths are used to measure
genetic differences). These time points were also characterized
by low diversity and a relatively balanced tree topology. In
contrast, high diversity and asymmetric topology, as observed
for V19–24, led to long branch lengths separating the ancestral
sequence from the other two.
A temporal ordering of the variants on a phylogenetic tree, as
we had previously described (Shankarappa et al., 1999), reflects
a dynamic turnover in the virus population. New mutations are
added in an iterative manner to the continually evolving
backbone sequence. With each sampled time point representing
a portion of this continuum, sequences designed to represent one
such portion would be best defined by a position at the center of
its tree space. Because of the temporal features inherent to these
sequences, the reconstructed centers of the tree space could be
shifted back with respect to time. Therefore, representative
sequences from one time point could even be more closely
related to variants from a prior time point, especially for an
ancestral sequence given the explicit design criteria. Fig. 4
illustrates a test of this reasoning by evaluating the difference in
genetic distances between the representative sequences and the
individual variants from its contemporary vs. the prior time
points. A preponderance of positive values for the current dataset
suggests that, on average, representative sequences are closer to
sequences from the contemporary time points. Such closer
relationship could be due to sampling frequency and/or the rate
of genetic change. However, the ancestral sequences from a few
time points did appear to be more closely related to sequences
from the prior time points. Such relationship for the earlyFig. 4. Comparison of variants from contemporary vs. prior time point for their ge
Genetic distances between representative sequences for each visit and the individu
differences were plotted. Positive values indicate that representative sequences are ge
values for visits 10, 19, and 24 indicate that these ancestral sequences were on averancestral sequence could be related to the homogenization of
sequences following the acute infection (Learn et al., 2002) and/
or an evolution towards the ancestral state (Herbeck et al., 2006).
Such a relationship for the later visits (V19 and V24) could be
the result of phylogenetic asymmetry, due to contributions from
different compartments (Nickle et al., 2003c).
We next evaluated the phylogenetic relationship between all
the 189 sequences used in this study by including the consensus,
ancestral, and COT sequences derived for each time point along
with the 150 individual variants in a single phylogram (Fig. 5).
This analysis was undertaken to examine how each represen-
tative sequence for different time points phylogenetically relate
to individual variants. We had previously documented the
strong temporal structure among the individual variants (Jensen
et al., 2003; Shankarappa et al., 1999), and the inclusion of
additional sequences did not appear to perturb the temporal
relationship. In addition, representative sequences derived from
each time point also clustered around variants from the
corresponding time points. Therefore, the derivation of
representative sequences did not induce any artifactual changes
causing the sequences to cluster in an aberrant manner.
Similarly, each representative sequence encoded genetic
features that were adequate and specific to lead them to cluster
with the sequences they were derived from. Additional
validation of this reasoning was found when each set of
representative sequences showed a rough clustering according
to the time of their sampling (in the inset of Fig. 5). A
perturbation of this temporal order seen for sequences from the
later time points is consistent with the asymmetric phylogeny
for sequences sampled at these time points.netic similarity to the contemporary consensus, ancestral, and COT sequences.
al sequences for the contemporary and the prior visits were derived, and the
netically closer to the contemporary sequences they were derived from. Negative
age, genetically closer to sequences sampled from the prior visit.
Fig. 5. Phylogenetic relationship among all the individual variants sampled over the 8-year/13-visit follow-up, along with the 39 representative sequences derived for
the pools of sequences sampled at each time point. Sequences were aligned to match codons, and the neighbor-joining phylogram was derived using model parameters
deduced for the entire dataset. Each of the representative sequences from different time points generally clustered closer to individual sequences from the
contemporaneous time point and were consistent with the overall temporal relationships observed for individual variants. The exceptions appear to be the ancestral
sequences corresponding to the last four time points that clustered close to each other. The inset illustrates the phylograms derived separately for the consensus,
ancestral, and COT sequences representing each time point.
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The centralized representative sequences derived and
analyzed earlier are appropriate targets to test immune reactivity
to autologous virus sequences. However, the cost and otherexperimental considerations, such as the availability of
cryopreserved cells, may make it difficult to test immune
reactivity to the entire panel of peptides corresponding to the
autologous viral sequence. Therefore, limiting the testing of
reactivity to regions corresponding to known cytotoxic T
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of candidate peptides targeted for screening. However, this
approach ignores the main reasons why autologous viral
sequences are needed to test the full immune reactivity, i.e.,
the effect of high inter-individual differences on the recognition
of new and unique CTL epitopes by different individuals.
Therefore, it is highly desirable to use additional and potentially
alternative methods to choose regions within the autologous
sequences that may be of immunologic significance.
By definition, ancestral sequence traces the path to a point
that represents the parental sequence for all the individual
variants. Under certain conditions such as an iterated
accumulation of mutations, an increasingly heterogeneous
group of variants could lead to an ancestral sequence that is
progressively more divergent from the variants. Therefore, the
reduced minimization of genetic distances by the ancestral
sequences, as compared to the consensus and COT sequences,
is consistent with this reasoning. In fact, for certain pools of
intra-individual virus variants, instead of minimizing the
distances, ancestral sequences led to an increased average
genetic distance, or the ancestral sequence from one time
point was more closely related to variants from an earlier time
point (Figs. 2 and 4). Therefore, while the ancestral sequence
attempts to encode sequence elements present in the past, the
COT and consensus sequences reflect features most common
to the set of contemporary sequences. If the continual escape
from immune recognition is an ongoing iterative process, then
the ancestral sequence has a higher likelihood of encoding
sequences present prior to immune escape, whereas the
consensus and COT sequences encode changes that allowed
the virus to escape immune recognition. Based on this
reasoning, we hypothesize that the COT and consensus
sequences are best suited to test the breadth of immune
reactivity to contemporary viruses, and the ancestral
sequences are most appropriate to test immune reactivity
present prior to immune escape. It is possible that a large
fraction of differences between the ancestral and COT
sequences may in fact represent the actual mutations that
allowed the virus to escape immune responses. A reduction in
the number of candidate sequences made possible by the use
of representative sequences makes this a practical and rational
approach.
Testing CTL reactivity using the above strategy relies on the
extent of differences between COT and ancestral sequences. In
this study and until V18, we found one to five amino acid
differences between ancestral and COT sequences, and this
difference increased to 13–18 amino acids thereafter. When
these differences are small, as for the sequences from earlier
time points, sequences from multiple time points can be used to
derive an ancestor that can take one farther back along the tree.
On the other hand, if the differences are large, as in the instances
of contributions from the reservoir/compartments, it may be
necessary to identify such sequences (Nickle et al., 2003b) and
generate subsets to represent the contemporary and archival
variants. In general, the use of consensus or COT sequences
appears to be most informative for early infection samples,
whereas coupling the use of ancestral sequence with COT/consensus sequence will be more informative in identifying
potential escape mutations.
We also propose a second approach to choose reagents to test
for immune escape that is built around the argument that
immune recognition drives natural selection at selected sites of
the sequence. Therefore, identifying sites that show evidence for
positive selection identify reasonable targets to test for immune
recognition and escape. This argument is supported by the
dominant presence of positive selection over the course of
infection and its relationship to epitopes recognized by T
lymphocytes (Liu et al., 2004; Nielsen and Yang, 1998; Ross
and Rodrigo, 2002; Williamson, 2003; Zanotto et al., 1999). In
Fig. 6, we illustrate the amino acid sites that show evidence for
positive selection over the course of infection. We find multiple
contiguous positively selected sites downstream of V3, within
the V4 and V5 regions, as well as an overall increase in the
number of such sites over the course of infection. Many of these
sites also showed evidence for consistent positive selection over
the course of infection. Positively selected sites were also
observed within the two known CTL epitopes restricted by Pt
8's HLA (Korber et al., 2003). We propose that peptides derived
from regions that exhibit positive selection are candidates to test
for immune reactivity and are hypothesized to contain variants
that allow the virus to escape immune recognition. Since our goal
in this study was to identify and display all potential sites under
selection, we used less stringent criteria. In another study, Ross
and Rodrigo (2002) have reported a more rigorous assessment of
the positive selection, and under varying selection criteria and
values ofω (dN/dS), for sequences from this and other individuals
in our previous study (Shankarappa et al., 1999).
The final selection of peptides to test immune reactivity can
rely on a combination of the above approaches. The use of these
approaches may also depend on the type and frequency of
sampling sequences, level of variation, and the number of
candidate motifs identified. For example, the availability of a
large number of sequences sampled using rigorous criteria, such
as those involving care to prevent resampling of virus templates,
will allow an accurate reconstruction of the ancestral (Doria-
Rose et al., 2005) and COT sequences as well as test for positive
selection. If sequences from additional time points are available,
positively selected sites can be tracked over time to test for
fixation of mutations and to better define peptide candidates to
screen for immune escape.
Discussion
Deriving a centralized reconstructed sequence to represent a
population of variant sequences for use in vaccine is a novel
approach and is being pursued aggressively in the development
of an AIDS vaccine immunogen (Doria-Rose et al., 2005; Gao
et al., 2004; Gaschen et al., 2002; Learn and Mullins, 2000;
Mullins et al., 2004; Nickle et al., 2003a; Novitsky et al., 2002).
The derivation of reconstructed sequences at the inter- and intra-
individual levels has analogous conceptual bases but has not
been reported for the intra-individual variants. Here, we show
that early stages of chronic infection are characterized by
phylogenetic symmetry and similar minimization of genetic
Fig. 6. Changes in amino acid sites exhibiting evidence for positive selection over the course of infection. The consensus amino acid sequence is shown at the top and the identity of the time point is shown on the left.
Highlighting the position corresponding to the amino acid at each visit identifies sites that show evidence for positive selection. Also illustrated are the positions corresponding to the three variable regions and the two
CTL epitopes restricted by HLA-A0201 and -B7, encoded by this individual.
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the other hand, variants from later stages of disease exhibit a
more complex phylogeny, marked by asymmetry and potential
contributions from the reservoirs and compartments. These
changes can lead to significant differences in the minimization
of genetic distances by the ancestral vs. other methods of
reconstructing centralized representative sequences. The pres-
ence of these differences illustrates the changing landscape of
viral evolution over the course of infection. These changes also
underscore the importance of undertaking these analyses in
choosing autologous sequences, as opposed to choosing a
cloned sequence at random, for immune reactivity and
immunotherapeutic studies.
We propose that eliciting and detecting maximal immune
responses are two sides of the same issue, and hence, the
approaches being used in one are applicable to the other. Just as
high viral diversity has impacted the development of a vaccine,
we contend that a full understanding of the correlates for
protective immune reactivity has also been influenced by the
differences between viral sequences used to test immune
responses and those present in the infected individual. The
30% enhancement in the number of CTL epitopes identified
using autologous vs. subtype consensus sequence (Altfeld et al.,
2003) could be an underestimate for two reasons. Other genes
such as Env that were not used in this study are much more
divergent, and the use of enhanced antigen presentation by
dendritic cells can elicit stronger and new immune reactivities.
A more parsimonious explanation for the clustering of CTL
epitopes to conserved regions (Yusim et al., 2002) is in the
identification of most epitopes using reagents based on the
prototype sequences. A CTL response that is somehow most
pronounced to a clustered set of conserved regions is not
consistent with a highly complex profile of T cell responses
(Addo et al., 2003; Altfeld et al., 2003; Frahm et al., 2004;
Kaufmann et al., 2004; Yu et al., 2002). The high levels of
variability observed within a time point in an individual and the
continual replacement of the population of variants by the new
and continually evolving variants (Shankarappa et al., 1999;
Wolinsky et al., 1996) are phenomena consistent with an active
and dynamic recognition by the immune system. But this
dynamism will not be apparent if the testing of immune
reactivity fails to consider the sequence differences.
We document significant differences in viral diversity and
phylogenetic relationship among sequences sampled at different
time points within an individual. Therefore, the use of methods
such as deriving a consensus sequence by bulk sequencing of
the variant pool would not be appropriate when the underlying
phylogenetic relationships differ. The choice of representative
sequence must also consider factors that underlie and influence
their derivation. Consensus sequence is derived using a simple
concept and methodology that links the most frequent or a
modal nucleotide or amino acid at each site. However, this
derivation is strongly influenced by the sampling artifacts:
inadequate sampling of sequences may lead to a biased
consensus and the artifactual resampling of viral templates
may lead to a wrong consensus sequence. In contrast, deriving
COT sequence involves the use of models of evolution toreconstruct the sequences (Nickle et al., 2003a) and hence is less
susceptible to sampling artifacts. On the other hand, ancestral
sequences are influenced by a different set of parameters and are
best illustrated by the effect of phylogenetic asymmetries
(Mullins et al., 2004; Nickle et al., 2003a). As previously
pointed out (Gao et al., 2003; Nickle et al., 2003a) and
illustrated here for V11 through V17 sequences, all three
sequences do not differ in the minimization of genetic distances
in the presence of near-symmetric phylogenies. However, even
though the differences between the three sequences have been
proposed to be of little statistical significance at the population
level and less relevant in the design of a vaccine (Gao et al.,
2003), we point out that at the intra-individual level, these
differences are highly relevant and must be considered.
In summary, we derive the consensus, ancestral, and COT
viral sequences to represent heterogeneous sets of HIV-1
variants sampled over time within an individual and analyze
their ability to minimize genetic distance to the variants. We
show the existence of significant differences in phylogenetic
relationship among variants present within an individual and
document how it may influence the minimization of genetic
distances by different sequences. Based on the number of issues
outlined in this study, the use of an autologous viral sequence
chosen at random from the pool of variants within an individual
is not optimal, and the design of sequences to represent such
pools should consider the nature of phylogenetic relationship
among the variants.
Materials and methods
HIV-1 infected subject and the env sequences
Pt 8 is a homosexual male enrolled in the Multicenter AIDS
Cohort Study (MACS) (Kaslow et al., 1987). Multiple env
C2V5 sequences, sampled at each of the 13 time points (Visits
V09 to V24) over the course of 8 years of infection, with earliest
sequences sampled at 4 months following seroconversion
(Shankarappa et al., 1999), were used in these analyses. All
the sequences used here were sampled prior to the use of highly
active combination anti-retroviral therapy in this individual. Pt
8 is among the group of individuals for which we had
characterized the virologic (Jensen et al., 2003; Shankarappa
et al., 1999; Shriner et al., 2004) and immunologic (Rinaldo
et al., 1998) features. Over the course of infection, Pt 8 env
sequences exhibited strong temporal features. Consistent with
the model we had proposed, X4 viruses in this individual
evolved at the beginning of stage II, reached a peak, and
declined in frequency. Overall, sequences sampled over the
course of infection in this subject represented a broad spectrum
of viral genetic changes, including a wide range of viral
diversity, divergence from early sequences, evolution of X4
viruses, and varying phylogenetic relationships. An average of
12 sequences with open reading frames was available from each
visit. Sequences from peripheral blood mononuclear cells
(PBMC) were available from all the 13 time points, and
sequences from plasma were also available from three of these
time points (V11, V15, V19).
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Sequences were aligned and edited to maintain the open
reading frame across gaps. Sequences corresponding to each
time point were stripped from the same overall alignment and
analyzed separately to derive the consensus, ancestral, and COT
sequences. For the consensus sequence, we first derived the
majority consensus DNA sequence for each time point. To
prevent superfluous amino acid resulting from the derivation of
consensus nucleotide sequence, each codon in the consensus
DNA sequence was checked, compared to the consensus amino
acid, and edited.
Ancestral sequences represent the most recent common
ancestor (MRCA) for the pool of variants and were derived in
PAML using the codon-based maximum likelihood methods
(Yang, 1997). Derivation of MRCA for each time point used
sequences from the time point along with a set of nine
phylogenetically unrelated prototype HIV-1 sequences as the
outgroup: HXB2 (K03455), JRFL (U63632), RF (M17451),
YU2X (M93258), SF2 (BD016767), NY5 (M38431), CAM1
(D10112), OYI (M26727), MNTQ (AF075719) (GenBank
accession numbers indicated in parenthesis). The starting trees
for sequences from each time point were derived using
maximum likelihood estimates for evolutionary parameters by
a two-step process using Paup* (Swofford, 2002), as described
by Anderson et al. (2001). Model parameters used in these
derivations included the codon frequencies estimated from the
average nucleotide frequencies at the three-codon positions.
Discrete model for dN/dS ratio (ω) was set to vary among sites
with three categories for the ω distribution. For the derivation of
COT sequences, a maximum likelihood tree was estimated in
PAUP*, and the center of the tree, the point in the tree having
the least squared distance to the branch tips (Nickle et al.,
2003a, 2003b, 2003c), was estimated and the corresponding
sequence reconstructed.
Comparing centralized representative sequences to individual
variants and identifying positively selected amino acid sites
The dataset of individual viral sequences and the corres-
ponding reconstructed consensus, ancestral, and COTsequences
from each time point were aligned and edited at the codon level
to derive a master alignment. This realignment maximized the
match for insertions and deletions that appeared over the course
of infection and was necessary for reconstructing the phyloge-
netic relationship for the entire dataset. Kimura-2 parameter
model of evolution and pairwise gap deletion were used inMega
ver 2.1 (Kumar et al., 2001) to estimate intra-time point diversity
(average of all pairwise DNA distances) as well as the DNA
distances between individual variants and the consensus,
ancestral, and COT sequences from each time point. Similarly,
amino acid distances were estimated as p-distances using Mega
(Kumar et al., 2001). Such simple models were intentionally
chosen to minimize the effect of differing evolutionary
parameters for sequences sampled over the course of infection
and to allow comparisons with earlier and other published
results. However, to reconstruct the phylogenetic relationshipbetween representative sequences and the individual viral
sequences, neighbor-joining phylograms were derived using
maximum likelihood distances estimated in Paup* (Swofford,
2002). Model parameters for the entire set of sequences in the
master alignment were used and were as follows: equilibrium
nucleotide frequencies: fA = 0.3841, fC = 0.1722, fG = 0.2205,
fT = 0.2232; proportion of invariable sites = 0.1804; shape
parameter (α) of the Γ distribution reflecting site-to-site rate
variability of variable sites: α = 0.4205; and theRmatrix values:
RA→C = 1.358, RA→G = 3.584, RA→T = 0.801, RC→G = 0.349,
RC→T = 3.358, RG→T = 1.
It would be desirable to identify and partition mutations of
potential biologic importance from the large spectrum typically
observed in an individual. Within Env, the biologic functions
most associated with viral genetic changes are the recognition
by immune system and the cell tropism. In view of the
documented predominance of positive selection within sites
recognized by the immune effector cells (Liu et al., 2004; Ross
and Rodrigo, 2002), we sought to identify positively selected
sites in the current dataset. We hypothesized that a de novo
identification of such positively selected sites would help
identify regions targeted for assessing CTL reactivity and limit
the number of peptides needed to be synthesized. To test for
positive selection, we used model parameters of evolution
applicable to sequences from each time point along with a
discrete model for selection with a single dN/dS ratio and using
PAML (Yang, 1997). Positively selected sites for sequences
from each time point were then compared to identify patterns of
change over the course of infection.
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